Drug delivery formulation impacts cyclosporine efficacy in a humanised mouse model of acute graft versus host disease.

Corbett, Jennifer M; Hawthorne, Ian; Coulter, Ivan S; English, Karen

Corbett, Jennifer M; Hawthorne, Ian; Coulter, Ivan S; English, Karen.

Afiliación

Corbett JM; Cellular Immunology Laboratory, Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland.
Hawthorne I; Cellular Immunology Laboratory, Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland.
Coulter IS; Sigmoid Pharma Ltd., The Invent Centre, Dublin City University, Dublin, Ireland.
English K; Cellular Immunology Laboratory, Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland; Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Co. Kildare, Ireland. Electronic address: karen.english@mu.ie.

Transpl Immunol ; 65: 101373, 2021 04.

Article en En | MEDLINE | ID: mdl-33592300

Asunto(s)

Enfermedad Injerto contra Huésped; Preparaciones Farmacéuticas; Administración Oral; Animales; Ciclosporina/uso terapéutico; Sistemas de Liberación de Medicamentos; Enfermedad Injerto contra Huésped/tratamiento farmacológico; Humanos; Ratones

Palabras clave

Cyclosporine; Drug delivery; Drug formulation; Graft versus host disease; Humanised mouse model; Immunosuppression

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Enfermedad Injerto contra Huésped Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Transpl Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google